Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

Summary

The study examined the efficacy of LCZ696 in comparison to the ARB olmesartan on Central Aortic Systolic Blood Pressure (CASP) and other measures of central hemodynamics and arterial stiffness in elderly patients with an elevated systolic blood pressure (SBP) and widened pulse pressure (PP).

Timeline

Start

2012-12

Primary completion

2015-04

Completion

2015-04

Outcome

Met primary endpoint

registry analysis (superiority or other test); LCZ696 (Sacubitril/Valsartan) vs Olmesartan; p = 0.010; Mean Difference (Net) -3.66 (95% CI -6.45 to -0.87); ANCOVA NCT01692301 ↗

Publications

• Williams B, Cockcroft JR, Kario K, Zappe DH, Cardenas P, Hester A, Brunel P, Zhang J. Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study. BMJ Open. 2014 Feb 4;4(2):e004254. doi: 10.1136/bmjopen-2013-004254.

Drugs

Indications